Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment

Neurology

Volumn 78, Issue 14, 2012, Pages 1079-1084

  Eftimov, F ^a   Vermeulen, M ^a   Van Doorn, P A ^b   Brusse, E ^b   Van Schaik, I N ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PREDNISOLONE;

ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CLOSED ANGLE GLAUCOMA; COHORT ANALYSIS; CUSHING DISEASE; DIABETES MELLITUS; DRUG PULSE THERAPY; FOLLOW UP; FRACTURE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MULTIPLE CYCLE TREATMENT; OSTEOPENIA; PRIORITY JOURNAL; REMISSION; SHORT COURSE THERAPY; TREATMENT RESPONSE;

EID: 84860752168     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31824e8f84     Document Type: Article

References (11)

1. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society: First revision. Eur J Neurol 2010;17:356-363.
2. RMC Trial Group. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): A pilot, multicentre study. Lancet Neurol 2009;8:158-164.
3. Hughes RA, Donofrio P, Bril V, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): A randomised placebo-controlled trial. Lancet Neurol 2008;7:136-144.
4. van Schaik IN, Eftimov F, Van Doorn PA, et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): A double-blind, randomised, controlled trial. Lancet Neurol 2010;9:245-253.
5. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. Int Disabil Stud 1991;13: 50-54.
6. Hughes R, Bensa S, Willison H, et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201. (Pubitemid 32738144)
7. Gorson KC, van Schaik IN, Merkies IS, et al. Chronic inflammatory demyelinating polyneuropathy disease activity status: Recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst 2010;15: 326-333.
8. Merkies IS, Schmitz PI, Samijn JP, Meche FG, Toyka KV, Van Doorn PA. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve 2000;23:1393-1401.
9. Merkies IS, Schmitz PI, van der Meche FG, Van Doorn PA. Psychometric evaluation of a new sensory scale in immunemediated polyneuropathies: Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 2000;54: 943-949. (Pubitemid 30111356)
10. Merkies IS, Schmitz PI, van der Meche FG, Van Doorn PA. Reliability and responsiveness of a graduated tuning fork in immune mediated polyneuropathies: The Inflammatory Neuropathy Cause and Treatment (INCAT) Group. J Neurol Neurosurg Psychiatry 2000;68:669-671. (Pubitemid 30248840)
11. Cheng Y, Wong RS, Soo YO, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003;349:831-836. (Pubitemid 37025402)